International Rare Disease Day

"Patients and Researchers: Partners for Life!"
PARIS, February 24, 2010 – For this annual event hundreds of patient groups and their
partners organise activities to raise awareness on rare diseases and the 30
million people affected by them in Europe.

Rare Disease Day was launched and is coordinated by the
European Organisation for Rare Diseases [...]

Shire Provides Update on Biologics License Application (BLA) Filing for REPLAGAL(R) (agalsidase alfa) With the U.S. Food and Drug Administration (FDA)

CAMBRIDGE, Massachusetts, February 24, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announces it has received Fast Track designation
from the FDA for REPLAGAL(R) (agalsidase alfa), its enzyme replacement
therapy for Fabry disease.

Shire filed a BLA for REPLAGAL in December 2009. The FDA requested
additional human pharmacokinetic data to [...]

First Awards Made by London Genetics’ Proof-of-Concept Fund

LONDON, February 24, 2010 – London Genetics Limited, an expert in the use of pharmacogenetics in
clinical drug discovery and development, has awarded the first three grants
from its proof-of-concept (POC) fund. The awards, to teams at Imperial
College London and University College London, are for research in the areas
of immunotherapy, schizophrenia and heart disease. Financial details [...]

Sanmina-SCI Tatabanya, Hungary Facility Achieves ISO 13485 Certification for Medical Devices

SAN JOSE, California, February 24, 2010 – Sanmina-SCI Corporation (Nasdaq: SANM), a leading global Electronics
Manufacturing Services (EMS) company, today announced that its Tatabanya,
Hungary facility has received ISO 13485 certification for medical device
manufacturing.

ISO 13485 is an internationally recognized standard developed to ensure
that companies provide medical devices that consistently meet regulatory
requirements. In [...]

IPO Prospects High on the Agenda at BioTrinity

Venue: Newbury Racecourse From Apr 12-14 2010
LONDON, February 24, 2010 – First Quarter of 2010 has shown some early signs of resurgence in life
science IPO's that are already underway or planned. BioTrinity, the UK's
Premier Biopartnering and Investment Conference, will be focusing on the
evidence for early success and the prospects for the remainder of the [...]

Star Scientific Files Application with FDA for Ariva-BDL(TM) Approval as First Modified Risk Tobacco Product

GLEN ALLEN, Virginia, February 24, 2010 – Star Scientific, Inc. (Nasdaq: CIGX) announced that on Friday, February
19 the company filed an application with the Food & Drug Administration for
approval to market Ariva-BDL(TM) as a "modified risk" tobacco product under
the Family Smoking Prevention and Tobacco Control Act of 2009. This
submission is the first such application [...]

Princess Haya Calls for Action to Protect Health in the Developing World

GENEVA, February 24, 2010 – Tobacco use encouraged by aggressive marketing and growing obesity linked
to poor diets and physical inactivity endanger millions of people in the
developing world, Princess Haya Al Hussein of Jordan said today at a
conference hosted by the World Health Organization (WHO).

In a keynote address at the Noncommunicable [...]